{ "release_id": "f4600233112e1c27", "id": "cardio:guide-prevention-recommendations", "owner": "cardio", "kind": "patient_guide", "slug": "prevention-recommendations", "name": "Heart prevention recommendations by age", "aliases": [], "atlases": [ "cardio" ], "summary_plain": "Which USPSTF recommendations exist on blood pressure screening, statins and aspirin, which ages and risk groups each one names, and questions to ask a clinician.", "summary_technical": "A static guide to three US Preventive Services Task Force recommendations, written from USPSTF pages and abstracts. It gives no advice for one reader.", "editorial_state": "draft", "last_substantive_edit": "2026-10-15", "last_evidence_check": "2026-10-15", "next_review_due": "2027-04-15", "identifiers": [], "navigation": { "cardio": { "condition-area": [ "risk-and-prevention" ] } }, "payload": { "purpose": "explainer", "audience": "Adults, and the people who care for them", "about": [ "cardio:guideline-uspstf-2021-hypertension-screening", "cardio:guideline-uspstf-2022-statin", "cardio:guideline-uspstf-2022-aspirin", "cardio:estimated-10-year-cvd-risk", "cardio:cardiovascular-prevention" ], "reading_grade_target": 10, "scope_note": "Covers three USPSTF recommendations only, not every USPSTF or other group’s prevention advice. Written from USPSTF pages and abstracts. It describes what the sources say and gives no advice for one person.", "warning_blocks": [], "sections": [ { "heading": "About the USPSTF", "statements": [ { "id": "who-1", "text": "The U.S. Preventive Services Task Force (USPSTF) is a volunteer panel of experts that makes recommendations on preventive services.", "cites": [ { "snapshot_id": "core:uspstf-about-2026-10-14", "locator": "Who We Are, sentence 1" }, { "snapshot_id": "core:uspstf-about-2026-10-14", "locator": "Who We Are, sentence 2, first part" } ] }, { "id": "who-2", "text": "The USPSTF says its advice is meant only for people without symptoms or other signs of the condition in question.", "cites": [ { "snapshot_id": "core:uspstf-about-2026-10-14", "locator": "What We Do, sentence 3, first part" } ] }, { "id": "who-3", "text": "The USPSTF says clinical decisions involve more than the evidence, and clinicians should adapt them to each patient.", "cites": [ { "snapshot_id": "cardio:uspstf-htn-page-2026-10-15", "locator": "USPSTF web page, Clinician Summary, closing paragraph, sentence 1" }, { "snapshot_id": "cardio:uspstf-htn-page-2026-10-15", "locator": "USPSTF web page, Clinician Summary, closing paragraph, sentence 2" } ] } ] }, { "heading": "How the USPSTF grades a recommendation", "statements": [ { "id": "grade-1", "text": "Each USPSTF recommendation receives a letter grade from A to D, or an I statement.", "cites": [ { "snapshot_id": "core:uspstf-about-2026-10-14", "locator": "What We Do, sentence 1, first part" }, { "snapshot_id": "cardio:uspstf-grade-definitions-2026-10-15", "locator": "Page introduction, sentence 1 (part)" } ] }, { "id": "grade-2", "text": "A grade reflects how strong the evidence is and how benefits compare with harms, and the USPSTF says it does not weigh cost.", "cites": [ { "snapshot_id": "core:uspstf-about-2026-10-14", "locator": "What We Do, sentence 1, last part" }, { "snapshot_id": "core:uspstf-about-2026-10-14", "locator": "What We Do, sentence 2" } ] }, { "id": "grade-a", "text": "Grade A means the USPSTF recommends a service and has high certainty that its overall benefit is substantial.", "cites": [ { "snapshot_id": "cardio:uspstf-grade-definitions-2026-10-15", "locator": "Grade table for votes after July 2012, grade A" } ] }, { "id": "grade-b", "text": "Grade B means a recommendation with high certainty of a moderate benefit, or moderate certainty of a moderate to substantial one.", "cites": [ { "snapshot_id": "cardio:uspstf-grade-definitions-2026-10-15", "locator": "Grade table for votes after July 2012, grade B, part 1 of 2" }, { "snapshot_id": "cardio:uspstf-grade-definitions-2026-10-15", "locator": "Grade table for votes after July 2012, grade B, part 2 of 2" } ] }, { "id": "grade-c", "text": "Grade C means the USPSTF recommends offering a service selectively, guided by clinician judgment and patient wishes, and is at least moderately certain that the overall benefit is small.", "cites": [ { "snapshot_id": "cardio:uspstf-grade-definitions-2026-10-15", "locator": "Grade table for votes after July 2012, grade C, part 1 of 2" }, { "snapshot_id": "cardio:uspstf-grade-definitions-2026-10-15", "locator": "Grade table for votes after July 2012, grade C, part 2 of 2" } ] }, { "id": "grade-d", "text": "Grade D means the USPSTF recommends against a service, being moderately or highly certain that it gives no benefit overall or does more harm than good.", "cites": [ { "snapshot_id": "cardio:uspstf-grade-definitions-2026-10-15", "locator": "Grade table for votes after July 2012, grade D, part 1 of 2" }, { "snapshot_id": "cardio:uspstf-grade-definitions-2026-10-15", "locator": "Grade table for votes after July 2012, grade D, part 2 of 2" } ] }, { "id": "grade-i", "text": "An I statement means the USPSTF could not tell whether a service does more good than harm, because the evidence is lacking, of low quality or conflicting.", "cites": [ { "snapshot_id": "cardio:uspstf-grade-definitions-2026-10-15", "locator": "Grade table for votes after July 2012, I statement, part 1 of 2" }, { "snapshot_id": "cardio:uspstf-grade-definitions-2026-10-15", "locator": "Grade table for votes after July 2012, I statement, part 2 of 2" } ] } ] }, { "heading": "Where the age ranges start and end", "statements": [ { "id": "age-1", "text": "The blood pressure screening recommendation starts at age 18, and the statin and aspirin recommendations start at age 40 for adults with no cardiovascular disease.", "cites": [ { "claim": "cardio:claim-uspstf-2021-hypertension-screening-a" }, { "snapshot_id": "cardio:uspstf-statin-page-2026-10-15", "locator": "USPSTF web page, Clinician Summary, who it applies to, sentence 1" }, { "snapshot_id": "cardio:uspstf-aspirin-page-2026-10-15", "locator": "USPSTF web page, Clinician Summary, who it applies to, part 1 of 4" } ] }, { "id": "age-2", "text": "For adults with no cardiovascular disease, the USPSTF recommends against starting aspirin as prevention from age 60, and from age 76 it finds the evidence too limited on starting a statin.", "cites": [ { "claim": "cardio:claim-uspstf-2022-aspirin-60-plus-d" }, { "claim": "cardio:claim-uspstf-2022-statin-76-plus-i" } ] } ] }, { "heading": "Blood pressure screening", "statements": [ { "id": "bp-1", "text": "The USPSTF’s 2021 statement on blood pressure screening covers adults aged 18 or older with no known high blood pressure.", "cites": [ { "claim": "cardio:claim-uspstf-2021-hypertension-screening-a" }, { "snapshot_id": "cardio:uspstf-htn-page-2026-10-15", "locator": "USPSTF web page, Recommendation Summary, population" }, { "snapshot_id": "cardio:uspstf-htn-page-2026-10-15", "locator": "USPSTF web page, Page header, date line" } ] }, { "id": "bp-2", "text": "It is a grade A recommendation, reaffirmed from 2015, with high certainty of a substantial net benefit.", "cites": [ { "claim": "cardio:claim-uspstf-2021-hypertension-screening-a" } ] }, { "id": "bp-3", "text": "It recommends screening with a blood pressure reading taken in the office, then readings outside the clinic to confirm a diagnosis before treatment.", "cites": [ { "claim": "cardio:claim-uspstf-2021-hypertension-screening-a" } ] }, { "id": "bp-4", "text": "The USPSTF page says evidence on the best screening interval is limited, so it lists reasonable options.", "cites": [ { "snapshot_id": "cardio:uspstf-htn-page-2026-10-15", "locator": "USPSTF web page, Clinician Summary, screening interval, lead-in" } ] }, { "id": "bp-5", "text": "One option is yearly screening from age 40, and from age 18 for adults who face higher risk.", "cites": [ { "snapshot_id": "cardio:uspstf-htn-page-2026-10-15", "locator": "USPSTF web page, Clinician Summary, screening interval, first option, part 1 of 2" } ] }, { "id": "bp-6", "text": "Its examples of higher risk include Black adults, adults whose blood pressure is high-normal, and adults who are overweight or have obesity.", "cites": [ { "snapshot_id": "cardio:uspstf-htn-page-2026-10-15", "locator": "USPSTF web page, Clinician Summary, screening interval, first option, part 2 of 2" } ] }, { "id": "bp-7", "text": "Another option, as appropriate, is screening every three to five years for adults between 18 and 39 who are not at higher risk and had a normal reading before.", "cites": [ { "snapshot_id": "cardio:uspstf-htn-page-2026-10-15", "locator": "USPSTF web page, Clinician Summary, screening interval, second option, part 1 of 2" }, { "snapshot_id": "cardio:uspstf-htn-page-2026-10-15", "locator": "USPSTF web page, Clinician Summary, screening interval, second option, part 2 of 2" } ] } ] }, { "heading": "Statins", "statements": [ { "id": "st-1", "text": "The USPSTF’s 2022 statin statement covers adults aged 40 or older with no cardiovascular disease and no sign or symptom of it.", "cites": [ { "claim": "cardio:claim-uspstf-2022-statin-b" }, { "snapshot_id": "cardio:uspstf-statin-page-2026-10-15", "locator": "USPSTF web page, Clinician Summary, who it applies to, sentence 1" }, { "snapshot_id": "cardio:uspstf-statin-page-2026-10-15", "locator": "USPSTF web page, Page header, date line" } ] }, { "id": "st-2", "text": "For adults between 40 and 75 who have at least one risk factor and whose estimated 10-year risk is 10% or more, it advises prescribing a statin (grade B).", "cites": [ { "claim": "cardio:claim-uspstf-2022-statin-b" } ] }, { "id": "st-3", "text": "The risk factors it names are abnormal blood fats, diabetes, high blood pressure and smoking.", "cites": [ { "claim": "cardio:claim-uspstf-2022-statin-b" } ] }, { "id": "st-4", "text": "It judges the net benefit in this group to be at least moderate, with moderate certainty.", "cites": [ { "claim": "cardio:claim-uspstf-2022-statin-b" } ] }, { "id": "st-5", "text": "For adults between 40 and 75 who have at least one of these risk factors and whose estimated 10-year risk is 7.5% to under 10%, the USPSTF advises offering a statin selectively (grade C), with a smaller likelihood of benefit.", "cites": [ { "claim": "cardio:claim-uspstf-2022-statin-c" } ] }, { "id": "st-6", "text": "From age 76, the USPSTF finds the evidence too limited to judge whether starting a statin does more good than harm (an I statement).", "cites": [ { "claim": "cardio:claim-uspstf-2022-statin-76-plus-i" } ] }, { "id": "st-7", "text": "In reply to comments, the USPSTF repeated that its statement is about starting a statin, when asked about adults aged 76 or older who already take one.", "cites": [ { "snapshot_id": "cardio:uspstf-statin-page-2026-10-15", "locator": "USPSTF web page, Response to Public Comment, sentence 6 (part)" }, { "snapshot_id": "cardio:uspstf-statin-page-2026-10-15", "locator": "USPSTF web page, Response to Public Comment, sentence 5" } ] }, { "id": "st-8", "text": "The USPSTF says the statin statement leaves out adults whose LDL cholesterol is above 190 mg/dL and adults with known familial hypercholesterolemia.", "cites": [ { "snapshot_id": "cardio:uspstf-statin-page-2026-10-15", "locator": "USPSTF web page, Clinician Summary, who it applies to, sentence 2" } ] }, { "id": "st-9", "text": "The page describes these adults as being at very high risk and points to other organizations’ guidelines for them.", "cites": [ { "snapshot_id": "cardio:uspstf-statin-page-2026-10-15", "locator": "USPSTF web page, Clinician Summary, who it applies to, sentence 3, part 1 of 2" }, { "snapshot_id": "cardio:uspstf-statin-page-2026-10-15", "locator": "USPSTF web page, Clinician Summary, who it applies to, sentence 3, part 2 of 2" } ] } ] }, { "heading": "The 10-year risk estimate", "statements": [ { "id": "rk-1", "text": "The statin and aspirin groups depend partly on an estimated chance of a cardiovascular event over 10 years.", "cites": [ { "claim": "cardio:claim-estimated-10-year-cvd-risk-use" } ] }, { "id": "rk-1b", "text": "The cut-offs are 10% and 7.5% for statins and 10% for aspirin.", "cites": [ { "claim": "cardio:claim-estimated-10-year-cvd-risk-use" } ] }, { "id": "rk-2", "text": "For clinicians, the USPSTF pages list estimating this risk with a risk estimator as a step in using these recommendations.", "cites": [ { "snapshot_id": "cardio:uspstf-statin-page-2026-10-15", "locator": "USPSTF web page, Clinician Summary, putting it into practice, step 2" }, { "snapshot_id": "cardio:uspstf-aspirin-page-2026-10-15", "locator": "USPSTF web page, Clinician Summary, putting it into practice, adults 40 to 59 step" } ] } ] }, { "heading": "Aspirin", "statements": [ { "id": "as-1", "text": "The USPSTF’s 2022 aspirin statement covers adults aged 40 or older with no cardiovascular disease, no sign or symptom of it and no raised risk of bleeding.", "cites": [ { "claim": "cardio:claim-uspstf-2022-aspirin-40-59-c" }, { "snapshot_id": "cardio:uspstf-aspirin-page-2026-10-15", "locator": "USPSTF web page, Clinician Summary, who it applies to, part 1 of 4" }, { "snapshot_id": "cardio:uspstf-aspirin-page-2026-10-15", "locator": "USPSTF web page, Clinician Summary, who it applies to, part 2 of 4" }, { "snapshot_id": "cardio:uspstf-aspirin-page-2026-10-15", "locator": "USPSTF web page, Page header, date line" } ] }, { "id": "as-2", "text": "The USPSTF’s examples of raised bleeding risk include recent bleeding, past digestive tract ulcers, other medical conditions and medicines that increase bleeding risk.", "cites": [ { "snapshot_id": "cardio:uspstf-aspirin-page-2026-10-15", "locator": "USPSTF web page, Clinician Summary, who it applies to, part 3 of 4" }, { "snapshot_id": "cardio:uspstf-aspirin-page-2026-10-15", "locator": "USPSTF web page, Clinician Summary, who it applies to, part 4 of 4" } ] }, { "id": "as-3", "text": "For adults between 40 and 59 whose risk over 10 years is estimated at 10% or more, the USPSTF says starting low-dose aspirin as prevention should be decided case by case (grade C).", "cites": [ { "claim": "cardio:claim-uspstf-2022-aspirin-40-59-c" } ] }, { "id": "as-4", "text": "It calls the net benefit small, with moderate certainty.", "cites": [ { "claim": "cardio:claim-uspstf-2022-aspirin-40-59-c" } ] }, { "id": "as-4b", "text": "It says people who are not at raised bleeding risk and are prepared to take a low dose every day have a better chance of benefit.", "cites": [ { "claim": "cardio:claim-uspstf-2022-aspirin-40-59-c" } ] }, { "id": "as-5", "text": "For adults 60 or older with no cardiovascular disease, the USPSTF recommends against starting low-dose aspirin as prevention (grade D).", "cites": [ { "claim": "cardio:claim-uspstf-2022-aspirin-60-plus-d" } ] }, { "id": "as-5b", "text": "It reports moderate certainty that starting aspirin at this age has no net benefit.", "cites": [ { "claim": "cardio:claim-uspstf-2022-aspirin-60-plus-d" } ] }, { "id": "as-6", "text": "The page says aspirin lowers the chance of cardiovascular events but raises the chance of bleeding in the digestive tract, bleeding inside the skull and stroke caused by bleeding.", "cites": [ { "snapshot_id": "cardio:uspstf-aspirin-page-2026-10-15", "locator": "USPSTF web page, Clinician Summary, additional information, bullet 3" } ] }, { "id": "as-7", "text": "The USPSTF words its aspirin and statin recommendations as being about starting the medicine.", "cites": [ { "snapshot_id": "cardio:uspstf-aspirin-page-2026-10-15", "locator": "USPSTF web page, Clinician Summary, the recommendation, adults 40 to 59 group" }, { "snapshot_id": "cardio:uspstf-aspirin-page-2026-10-15", "locator": "USPSTF web page, Clinician Summary, the recommendation, adults 60 or older group" }, { "snapshot_id": "cardio:uspstf-statin-page-2026-10-15", "locator": "USPSTF web page, Clinician Summary, the recommendation, first group" } ] } ] }, { "heading": "Guidance from other groups", "statements": [ { "id": "og-1", "text": "A 2026 guideline from the American College of Cardiology, the American Heart Association and other societies replaces the 2018 guideline on managing blood cholesterol.", "cites": [ { "claim": "cardio:claim-acc-aha-2026-dyslipidemia-replaces-2018" } ] } ] } ], "checklists": [], "questions": [ { "text": "Which of the screening options on the USPSTF page fits my age and risk, and how often will my blood pressure be checked?", "grounded_in": [ "bp-4", "bp-5", "bp-7" ] }, { "text": "Do I have any of the risk factors the statin recommendation names, and what is my estimated chance of a cardiovascular event over 10 years?", "grounded_in": [ "st-3", "rk-1", "rk-1b" ] }, { "text": "Which risk estimator is used to work out a 10-year risk, and which events does it count?", "grounded_in": [ "rk-2" ] }, { "text": "Do these recommendations apply to me if I have heart disease, very high LDL cholesterol or familial hypercholesterolemia?", "grounded_in": [ "st-1", "st-8", "as-1" ] }, { "text": "If I am 76 or older, what does it mean that the USPSTF finds the evidence too limited on starting a statin?", "grounded_in": [ "st-6", "st-7" ] }, { "text": "Am I at raised risk of bleeding, and how does that affect whether aspirin is an option for me?", "grounded_in": [ "as-1", "as-2", "as-6" ] }, { "text": "If I already take a statin or aspirin, do these recommendations about starting apply to me?", "grounded_in": [ "as-7", "st-7" ] }, { "text": "How do the USPSTF recommendations fit with other groups’ guidance on cholesterol?", "grounded_in": [ "og-1" ] } ] }, "content_digest": "4ce62ceeb284663dc08e9f59c8783bd50a39f38032d0e5024d1a9eebb4406735", "review": { "content_digest": "4ce62ceeb284663dc08e9f59c8783bd50a39f38032d0e5024d1a9eebb4406735", "current": [], "conflicting": [], "stale": [], "inactive": [] }, "claims": [], "decisions": [], "milestones": [], "relationships": { "outgoing": [], "incoming": [] }, "page_path": "guides/prevention-recommendations/", "context_path": "api/v1/context/cardio--guide-prevention-recommendations.md" }